Price
Financials
Standalone, Rs crore| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 14.37 | 16.69 | 17.84 | 20.55 | 23.01 | 19.02 |
| Expenses | 12.58 | 15.15 | 15.45 | 18.81 | 20.04 | 18.15 |
| Operating Profit | 1.79 | 1.54 | 2.39 | 1.74 | 2.97 | 0.87 |
| OPM % | 12.46% | 9.23% | 13.40% | 8.47% | 12.91% | 4.57% |
| Other Income | 0.48 | 0.76 | 0.73 | 0.59 | 0.39 | 0.28 |
| Interest | 0.24 | 0.28 | 0.18 | 0.14 | 0.25 | 0.18 |
| Depreciation | 0.26 | 0.30 | 0.34 | 0.49 | 0.43 | 0.46 |
| Profit before tax | 1.77 | 1.72 | 2.60 | 1.70 | 2.68 | 0.51 |
| Tax % | 26.55% | 23.26% | 30.00% | 10.59% | 26.87% | 33.33% |
| Net Profit | 1.30 | 1.33 | 1.83 | 1.51 | 1.97 | 0.34 |
| EPS in Rs | 2.04 | 2.09 | 2.11 | 1.74 | 2.28 | 0.39 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 26.41 | 40.63 | 36.47 | 27.86 | 31.07 | 38.39 | 42.03 |
| Expenses | 24.82 | 36.14 | 33.78 | 24.93 | 27.74 | 34.26 | 38.18 |
| Operating Profit | 1.59 | 4.49 | 2.69 | 2.93 | 3.33 | 4.13 | 3.85 |
| OPM % | 6.02% | 11.05% | 7.38% | 10.52% | 10.72% | 10.76% | 9.16% |
| Other Income | 0.04 | 0.10 | 0.29 | 0.46 | 1.25 | 1.32 | 0.67 |
| Interest | 0.47 | 0.24 | 0.41 | 0.47 | 0.52 | 0.32 | 0.43 |
| Depreciation | 0.52 | 0.51 | 0.54 | 0.69 | 0.56 | 0.83 | 0.88 |
| Profit before tax | 0.64 | 3.84 | 2.03 | 2.23 | 3.50 | 4.30 | 3.21 |
| Tax % | 25.00% | 25.00% | 28.08% | 30.49% | 24.86% | 22.33% | 27.73% |
| Net Profit | 0.48 | 2.88 | 1.47 | 1.55 | 2.63 | 3.34 | 2.31 |
| EPS in Rs | 173.29 | 1,039.71 | 530.69 | 559.57 | 4.13 | 3.86 | 2.67 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 1% | 15% | 9% | ||
| Compounded Profit Growth | % | -7% | 16% | 0% | ||
| Stock Price CAGR | % | % | % | 38% | ||
| Return on Equity | % | 14% | 12% | 8% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.28 | 0.28 | 0.28 | 0.28 | 6.36 | 8.66 | 8.66 |
| Reserves | 2.42 | 5.67 | 5.93 | 7.10 | 3.64 | 15.41 | 17.72 |
| Borrowings | 1.62 | 0.42 | 4.33 | 4.70 | 5.47 | 2.64 | 3.92 |
| Other Liabilities | 2.55 | 7.69 | 5.26 | 2.90 | 2.47 | 3.18 | 3.01 |
| Total Liabilities | 6.87 | 14.06 | 15.80 | 14.98 | 17.94 | 29.89 | 33.31 |
| Fixed Assets | 0.00 | 0.00 | 3.91 | 2.40 | 2.58 | 4.14 | 4.27 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.00 |
| Investments | 0.00 | 0.40 | 2.79 | 3.62 | 2.57 | 6.85 | 6.50 |
| Other Assets | 6.87 | 13.66 | 9.10 | 8.96 | 12.79 | 18.78 | 22.54 |
| Total Assets | 6.87 | 14.06 | 15.80 | 14.98 | 17.94 | 29.89 | 33.31 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0.00 | 0.00 | -0.25 | 0.01 | -0.66 | -0.31 | 1.18 |
| Cash from Investing Activity | 0.00 | 0.00 | -3.07 | -0.34 | 0.48 | -5.84 | -0.40 |
| Cash from Financing Activity | 0.00 | 0.00 | 2.59 | 0.31 | 0.24 | 7.58 | 0.86 |
| Net Cash Flow | 0.00 | 0.00 | -0.72 | -0.01 | 0.06 | 1.43 | 1.64 |
| Free Cash Flow | 0.00 | 0.00 | -2.40 | -0.01 | -1.82 | -3.04 | -0.08 |
| CFO/OP | 0% | 0% | 10% | 32% | 7% | 17% | 54% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 31.23 | 40.43 | 36.33 | 48.47 | 46.87 | 57.14 | 42.81 |
| Inventory Days | 4.54 | 4.18 | 28.03 | 46.61 | 92.57 | 112.95 | 124.73 |
| Days Payable | 41.76 | 82.57 | 64.42 | 44.46 | 33.99 | 36.44 | 28.98 |
| Cash Conversion Cycle | -5.98 | -37.96 | -0.06 | 50.62 | 105.45 | 133.65 | 138.56 |
| Working Capital Days | 10.78 | -8.62 | 21.12 | 54.11 | 56.15 | 103.92 | 96.40 |
| ROCE % | 76.33% | 28.86% | 20.87% | 22.36% | 16.88% | 12.03% |
| May 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Promoters | 73.43% | 73.43% | 73.43% | 73.44% | 73.44% | 73.43% | 73.43% | 73.44% | 73.44% |
| FIIs | 5.25% | 0.16% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DIIs | 6.28% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 15.03% | 26.41% | 26.55% | 26.56% | 26.57% | 26.57% | 26.57% | 26.56% | 26.56% |
| No. of Shareholders | 621 | 606 | 593 | 584 | 548 | 506 | 415 | 394 | 393 |
Fundamentals
Market Cap₹ 58.4 Cr.
Current Price₹ 67.5
Stock P/E28.6
Book Value₹ 30.5
ROCE12.0 %
ROE8.09 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)9%
Compounded Profit Growth (TTM)0%
Standalone figures.
Valuation
Market capRs 63 Cr
Enterprise valueRs 67 Cr
P/E (TTM)40.43x
Price to book8.49x
Price to sales2.25x
EV / EBITDA19.86x
EV / EBIT24.93x
EV / sales2.42x
Price to cash flow6266.09x
Earnings yield2.47%
Profitability
Operating margin (excl. other income)10.52%
Operating margin (incl. other income)12.17%
EBITDA margin12.17%
Pre-tax margin8.00%
Net profit margin5.56%
ROE22.81%
ROCE23.87%
ROA10.07%
ROE, 3-year average37.86%
ROCE, 3-year average43.02%
ROA, 3-year average15.81%
ROIC (approx.)15.60%
Tax rate30.49%
Other income / net worth6.23%
Growth
Sales growth (latest year)-23.61%
Profit growth (latest year)5.44%
Sales CAGR, 3 years1.80%
Profit CAGR, 3 years47.81%
Per share
EPS (TTM)Rs 1.79
EPS (latest year)Rs 560.21
EPS, 3-year averageRs 710.81
Book value per shareRs 8.53
Sales per shareRs 32.19
Cash flow per shareRs 0.01
Free cash flow per shareRs -0.09
Efficiency
Asset turnover1.86x
Fixed asset turnover11.61x
Inventory turnover8.02x
Inventory days46 days
Debtor days48 days
Debtors turnover7.53x
Creditor days29 days
Cash conversion cycle139 days
Working capital days96 days
Leverage
Total debtRs 5 Cr
Cash and bankRs 0 Cr
Net debtRs 5 Cr
Debt to equity0.64x
Net debt / EBITDA1.37x
Interest coverage5.74x
Owners' fund to total sources49.27%
Debt to assets31.38%
Cash flow
Cash from Operating Activity (latest year)Rs 0 Cr
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs 0 Cr
Net Cash Flow (latest year)Rs -0 Cr
Free cash flow (latest year)Rs -0 Cr
FCFE (approx.: FCF + change in debt)Rs 0 Cr
Cash from ops / profit, 5 years-0.00x
Sales to cash flow2786.00x
Statement figures
Net sales (TTM)Rs 28 Cr
Net sales (latest year)Rs 28 Cr
Operating profit excl. other income (latest year)Rs 3 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 3 Cr
PBDT (TTM)Rs 3 Cr
Profit before tax (TTM)Rs 2 Cr
Tax (latest year)Rs 1 Cr
Net profit (TTM)Rs 2 Cr
Net profit (latest year)Rs 2 Cr
Depreciation (TTM)Rs 1 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 21 Cr
Total expenditure (latest year)Rs 25 Cr
Total income (latest year)Rs 28 Cr
Share capitalRs 0 Cr
ReservesRs 7 Cr
Shareholders' fundsRs 7 Cr
Total assetsRs 15 Cr
Net blockRs 2 Cr
InvestmentsRs 4 Cr
ReceivablesRs 4 Cr
InventoryRs 3 Cr
Other liabilitiesRs 3 Cr
Shares outstanding (crore)0.87
Ownership
Promoter holding73.44% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 40.4 is at the 90th percentile of its own 2.5-year range
(median 27.7, low 11.9, high 120.5).
P/B 8.49 is at the 57th percentile (median 7.81).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 544169 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +13.2% | -2.8% | +15.9 pts |
| 1 month | +58.3% | -6.8% | +65.0 pts |
Red flags
F-score 5 of 8| explain | High accruals Profit exceeded operating cash by 10% of total assets in 2026 |
| explain | Receivables outrunning sales Receivables grew 2% vs sales -24% in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2026Sales ₹19 Cr +14.0% vs Mar 2024.
Net profit ₹0 Cr -74.4%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Poly Medicure Ltd | 16,671 | 52.1 | 12.5 % |
| Molbio Diagnostics Ltd | 14,470 | 66.6 | 18.0 % |
| Fischer Medical Ventures Ltd | 2,355 | 96.2 | 11.4 % |
| Tarsons Products Ltd | 1,754 | 148 | 4.59 % |
| Q-Line Biotech Ltd | 1,569 | 27.8 | 22.5 % |
| Laxmi Dental Ltd | 1,058 | 30.4 | 15.0 % |
| Hemant Surgical Industries Ltd | 869 | 51.3 | 18.9 % |
| Vasa Denticity Ltd | 754 | 62.3 | 7.54 % |
| OSEL Devices Ltd | 691 | 23.6 | 24.4 % |
| Prevest Denpro Ltd | 462 | 20.5 | 24.9 % |
| QMS Medical Allied Services Ltd | 419 | 39.0 | 12.9 % |
| Nureca Ltd | 349 | 80.4 | 3.30 % |
| Aprameya Engineering Ltd | 200 | 39.7 | 12.6 % |
| Avience Biomedicals Ltd | 198 | 22.7 | 27.0 % |
| Earkart Limited | 179 | 36.3 | 17.5 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Amkay Products Ltd?
Amkay Products Ltd (544169) has a market capitalisation of Rs 58.4 Cr. at the 2026-10-01 close.
What is the P/E ratio of Amkay Products Ltd?
Amkay Products Ltd trades at a P/E of 28.6 on trailing twelve-month profit, at the 2026-10-01 close.
What were Amkay Products Ltd's latest quarterly results?
In the Mar 2026 quarter, Amkay Products Ltd sales was Rs 19 Cr (+14.0% vs Mar 2024) and net profit was Rs 0 Cr.